微孔穿刺引流联合尿激酶治疗对脑出血后脑水肿程度及血清丙二醛、基质金属蛋白酶-9和细胞黏附分子-1水平的影响

Effects of minimally invasive puncture and drainage combined with urokinase on the severity of cerebral edema,serum malondialdehyde,matrix metalloproteinase-9 and intercellular adhesion molecule-1 after cerebral hemorrhage

目的观察微孔穿刺引流术(对照组)联合尿激酶(UK)治疗对脑出血后脑水肿程度及血清丙二醛(MDA)、基质金属蛋白酶-9(MMP-9)和细胞黏附分子-1(ICAM-1)水平的影响。方法2020年1月~2022年9月在我院收治的高血压性脑出血(HICH)病人82例,根据不同治疗方案分为两组,观察组44例,采用对照组联合UK治疗,对照组38例,采用对照组治疗。观察两组病人脑水肿体积、神经功能[美国国立卫生研究院卒中量表(NIHSS)]、血清学指标MDA、MMP-9和ICAM-1。记录术后并发症发生情况,对比两组术后3个月的预后情况[格拉斯哥结局量表评分(GOS)、日常生活能力(ADL)评分和死亡情况]。结果术后14天,观察组的周围脑水肿体积为(14.76±2.39)ml,低于对照组的(16.87±2.24)ml,差异有统计学意义(P<0.05);观察组NIHSS评分为(11.12±1.96)分,低于对照组的(11.96±1.65)分。两组比较,差异有统计学意义(P<0.05);观察组的血清MDA、MMP-9、ICAM-1水平分别为(8.65±1.16)nmol/ml、(96.17±19.34)ng/ml和(624.31±32.76)μg/ml,均低于对照组的(16.14±2.16)nmol/ml、(120.47±21.32)ng/ml和(661.24±35.21)μg/ml。两组比较差异有统计学意义(P<0.05)。观察组术后并发症发生率为9.09%,与对照组的18.42%比较,差异无统计学意义(P>0.05)。两组术后3个月内均无死亡病例。观察组术后3个月的GOS评分和ADL评分分别为(4.03±0.92)分、(71.21±12.65)分,均高于对照组的(3.52±1.12)分、(62.98±15.58)分,两组比较差异有统计学意义(P<0.05)。结论HICH病人应用对照组联合UK治疗可有效控制脑水肿,下调MDA、MMP-9、ICAM-1水平,保护神经功能,改善预后。

Objective To observe the effects of minimally invasive puncture and drainage combined with urokinase on the severity of cerebral edema,serum malondialdehyde(MDA),matrix metalloproteinase-9(MMP-9)and intercellular adhesion molecule-1(ICAM-1)after cerebral hemorrhage.Methods A total of 82 patients with hypertensive intracerebral hemorrhage(HICH)admitted to our hospital were retrospectively enrolled between January 2020 and September 2022.According to different treatment methods,they were divided into two groups:observation group(44 cases,control group combined with UK)and control group(38 cases,control treatment).The cerebral edema volume,nerve function[National Institutes of Health Stroke Scale(NIHSS)]and serological indexes(MDA,MMP-9,ICAM-1)in both groups were observed.The occurrence of postoperative complications was recorded.The prognosis[scores of Glasgow Outcome Scale(GOS)and activity of daily living scale(ADL),death]in the two groups was compared at 3 months after surgery.Results At 14d after surgery,peripheral cerebral edema volume in the observation group was smaller than that in the control group[(14.76±2.39)ml vs(16.87±2.24)ml,P<0.05],NIHSS score was lower than that in the control group[(11.12±1.96)points vs(11.96±1.65)points,P<0.05].The levels of serum MDA,MMP-9 and ICAM-1 in the observation group were(8.65±1.16)nmol/ml,(96.17±19.34)ng/ml and(624.31±32.76)μg/ml,respectively,which were lower than those in the control group[(16.14±2.16)nmol/ml,(120.47±21.32)ng/ml,(661.24±35.21)μg/ml,P<0.05].There was no significant difference in incidence of postoperative complications between the observation group and the control group(9.09%vs 18.42%,P>0.05).There was no death in either group within 3 months after surgery.At 3 months after surgery,GOS and ADL scores in the observation group were(4.03±0.92)points and(71.21±12.65)points,which were higher than those in the control group[(3.52±1.12)points,(62.98±15.58)points,P<0.05].Conclusion The control combined with UK can effectively control cerebral edema,down-regulate MDA,MMP-9 and ICAM-1 levels,protect nerve function and improve prognosis in HICH patients.